Parkside Advisors Portfolio holdings
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$5.37M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$2.44M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$2.03M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$1.85M |
| 5 |
iShares ESG Advanced MSCI EAFE ETF
DMXF
|
+$1.49M |
Top Sells
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$4.93M |
| 2 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$2.37M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.04M |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$1.67M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$1.12M |
Sector Composition
| 1 | Technology | 2.61% |
| 2 | Consumer Staples | 0.95% |
| 3 | Healthcare | 0.74% |
| 4 | Financials | 0.64% |
| 5 | Communication Services | 0.5% |
Similar funds
Parkside Advisors's Q4 2022 Portfolio in Review
As of Q4 2022, Parkside Advisors held 85 positions worth $286M, up 8.8% from $263M the previous quarter. Its ten largest holdings account for 70% of the portfolio.
Parkside Advisors deployed $9.34M of net new capital in Q4 2022, opening 25 new positions and adding to 27 existing holdings. Its largest new stake was Vanguard Short-Term Bond ETF: 27,030 shares worth $2.03M.
By sector, the portfolio is most concentrated in Technology at 2.6% of assets, down from 2.8% a quarter earlier, followed by Consumer Staples and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $4.93M trimmed.
- Parkside Advisors's largest Q4 2022 buy was Vanguard Short-Term Bond ETF: 27,030 shares worth $2.03M.
- Parkside Advisors added most to Vanguard FTSE Developed Markets ETF in Q4 2022, an estimated $5.37M increase.
- Parkside Advisors's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $4.93M.
- Parkside Advisors fully exited Tesla in Q4 2022, selling an estimated $269K.
- Parkside Advisors's ten largest holdings make up 70% of its $286M portfolio in Q4 2022.
- Parkside Advisors opened 25 new positions and closed 3 in Q4 2022.
- Parkside Advisors's portfolio value rose 8.8% quarter-over-quarter to $286M.
Based on Parkside Advisors's 13F filing for Q4 2022, filed 9 Jan 2023.